Non-superiority of zuranolone (SAGE-217) at the longer-term

F. ten Doesschate, J. A. van Waarde, G. A. van Wingen

Research output: Contribution to journal › Comment/Letter to the editor › Academic

9 Citations (Scopus)

Original language	English
Pages (from-to)	329-330
Number of pages	2
Journal	Journal of affective disorders
Volume	291
DOIs	https://doi.org/10.1016/j.jad.2021.05.015
Publication status	Published - 1 Aug 2021

Access to Document

@article{9e202da2ef454becab972e1587e2a029,

title = "Non-superiority of zuranolone (SAGE-217) at the longer-term",

author = "{ten Doesschate}, F. and {van Waarde}, {J. A.} and {van Wingen}, {G. A.}",

year = "2021",

month = aug,

day = "1",

doi = "https://doi.org/10.1016/j.jad.2021.05.015",

language = "English",

volume = "291",

pages = "329--330",

journal = "Journal of affective disorders",

issn = "0165-0327",

publisher = "Elsevier",

}

TY - JOUR

T1 - Non-superiority of zuranolone (SAGE-217) at the longer-term

AU - ten Doesschate, F.

AU - van Waarde, J. A.

AU - van Wingen, G. A.

PY - 2021/8/1

Y1 - 2021/8/1

UR - http://www.scopus.com/inward/record.url?scp=85107075906&partnerID=8YFLogxK

U2 - https://doi.org/10.1016/j.jad.2021.05.015

DO - https://doi.org/10.1016/j.jad.2021.05.015

M3 - Comment/Letter to the editor

C2 - 34082218

SN - 0165-0327

VL - 291

SP - 329

EP - 330

JO - Journal of affective disorders

JF - Journal of affective disorders

ER -